These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27006378)

  • 1. Early Events in the Molecular Pathogenesis of Lung Cancer.
    Kadara H; Scheet P; Wistuba II; Spira AE
    Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early detection of ovarian cancer: tomorrow? A review].
    Chene G; Penault-Llorca F; Robin N; Cayre A; Provencher DM; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 2013 Feb; 42(1):5-11. PubMed ID: 23182787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of biomarkers for early detection of lung cancer and chemoprevention.
    Hirsch FR; Merrick DT; Franklin WA
    Eur Respir J; 2002 Jun; 19(6):1151-8. PubMed ID: 12108871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Case for a Pre-Cancer Genome Atlas (PCGA).
    Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
    Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.
    Beane J; Mazzilli SA; Tassinari AM; Liu G; Zhang X; Liu H; Buncio AD; Dhillon SS; Platero SJ; Lenburg ME; Reid ME; Lam S; Spira AE
    Clin Cancer Res; 2017 Sep; 23(17):5091-5100. PubMed ID: 28533227
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical markers of cancerogenesis in the lung.
    Pankiewicz W; Minarowski L; Niklińska W; Naumnik W; Nikliński J; Chyczewski L
    Folia Histochem Cytobiol; 2007; 45(2):65-74. PubMed ID: 17597018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential biomarkers for the early detection of lung cancer.
    Gruidl ME; Shaw Wright GL
    J Thorac Imaging; 2000 Jan; 15(1):13-20. PubMed ID: 10634657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of lung cancer biomarkers through biosensor technology: A review.
    Roointan A; Ahmad Mir T; Ibrahim Wani S; Mati-Ur-Rehman ; Hussain KK; Ahmed B; Abrahim S; Savardashtaki A; Gandomani G; Gandomani M; Chinnappan R; Akhtar MH
    J Pharm Biomed Anal; 2019 Feb; 164():93-103. PubMed ID: 30366148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
    Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
    Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment.
    Saab S; Zalzale H; Rahal Z; Khalifeh Y; Sinjab A; Kadara H
    Front Immunol; 2020; 11():159. PubMed ID: 32117295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preinvasive lesions of the bronchus.
    Rivera MP
    Clin Chest Med; 2011 Dec; 32(4):693-702. PubMed ID: 22054880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Diagnosis and Screening for Lung Cancer.
    Kadara H; Tran LM; Liu B; Vachani A; Li S; Sinjab A; Zhou XJ; Dubinett SM; Krysan K
    Cold Spring Harb Perspect Med; 2021 Sep; 11(9):. PubMed ID: 34001525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.
    Beane JE; Mazzilli SA; Campbell JD; Duclos G; Krysan K; Moy C; Perdomo C; Schaffer M; Liu G; Zhang S; Liu H; Vick J; Dhillon SS; Platero SJ; Dubinett SM; Stevenson C; Reid ME; Lenburg ME; Spira AE
    Nat Commun; 2019 Apr; 10(1):1856. PubMed ID: 31015447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular origins of lung cancer: prospects for personalized prevention and therapy.
    Haura EB; Camidge DR; Reckamp K; Chiappori A; Johnson F; Herbst R; Wong K; Carbone D
    J Thorac Oncol; 2010 Jun; 5(6 Suppl 3):S207-13. PubMed ID: 20502275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer epigenetics and genetics.
    Risch A; Plass C
    Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.